Completed PHASE2 INTERVENTIONAL NCT00199771

Hypertonic Saline Dextran in Pediatric Cardiac Surgery

The Use of Hypertonic Saline Dextran in Cardiac Surgery Utilizing Cardio Pulmonary Bypass in Children Less Than 17 Weeks Old.

Sponsor: BioPhausia

Conditions Endocardial Cushion Defects Heart Defects, Congenital Heart Septal Defects, Ventricular Transposition of Great Vessels

Interventions 7.5% NaCl in 6% dextran 70 solution

Updated 6 times since 2017 Last updated: Jun 30, 2011 Started: Jun 30, 2003 Primary completion: Dec 31, 2004 Completion: Feb 28, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Endocardial Cushion Defects and Heart Defects, Congenital, this trial is completed. The trial is conducted by BioPhausia and has accumulated 6 data snapshots since 2003. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE2
Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

BioPhausia
Oslo University Hospital

Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.